Non-invasive Continuous Blood Glucose Monitoring & Mobile Health Management
Gluwatch Technology Co., Ltd. is a company specializing in the research and development of non-invasive blood glucose monitoring technology. Its R&D centers are located in Silicon Valley, USA, Shenzhen, China, and Tokyo, Japan. The company currently has more than 1,000 employees and has established six subsidiaries worldwide. The sales revenue for 2024 is expected to reach 790 million yuan. In recent years, the company’s products have been sold to regions including Europe, the United States, Japan, South Korea, and Southeast Asia.
According to the International Diabetes Federation (IDF), in 2021, there were 537 million people with diabetes globally, and diabetes caused at least 966 billion USD in healthcare expenses.
To help diabetes patients and doctors better manage this chronic disease that has long plagued the medical community, we developed a non-invasive blood glucose monitoring solution — the Gluwatch Non-Invasive Continuous Blood Glucose Monitoring Watch.
The Gluwatch Non-Invasive Continuous Blood Glucose Monitoring Watch integrates four monitoring methods based on multiple disciplines, including physics, optics, bioengineering, signal processing, and artificial intelligence algorithms. It uses optical sensors with different wavelengths to collect ECG (electrocardiogram) and PPG (photoplethysmogram) signals from the human body. The signals are then processed using advanced algorithms, and blood glucose levels are calculated based on an AI-based model tailored to individual users.
This solution addresses the pain points of traditional invasive testing methods while enabling diabetes patients to better track their blood glucose levels, helping to prevent further complications.
Each Cluwatch product is meticulously designed to enhance precision and convenience, offering an unparalleled and improved user experience.
